Today: 13 June 2026
Browse Category

EPA:ABVX 16 December 2025 - 2 June 2026

Abivax Stock Sees Big After-Hours Moves After Trial Result

Abivax Stock Sees Big After-Hours Moves After Trial Result

Abivax shares plunged 33.7% to $86.01 after hours on Nasdaq despite its ulcerative colitis drug obefazimod hitting the main goal in a 44-week Phase 3 trial. Both 25 mg and 50 mg doses showed over 50% clinical remission versus 10.4% for placebo. No new safety signals reported. Abivax plans a U.S. FDA filing late Q4 2026. Cash reserves stood at €491.6 million at March-end, funding into Q4 2027.
2 June 2026
···
ABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes EffectABIVAXABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes Effect

ABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes EffectABIVAXABIVAX Société Anonyme Stock (ABVX) Jumps on Fresh Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Takes Effect

Abivax shares jumped as much as 14% to €114.4 in Paris on Monday after reports of renewed takeover interest from Eli Lilly and the company’s addition to the Nasdaq Biotechnology Index. French outlet La Lettre reported Lilly representatives met with French Treasury officials this month about a potential deal, though Reuters said it could not confirm the meeting. Neither company commented on the rumors.
22 December 2025
··
ABIVAX (ABVX) Stock Surges on Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Kicks In — News, Forecasts and Outlook (Dec. 22, 2025)

ABIVAX (ABVX) Stock Surges on Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Kicks In — News, Forecasts and Outlook (Dec. 22, 2025)

Abivax shares jumped about 10% to $126 in early U.S. premarket trading after reports of renewed takeover speculation involving Eli Lilly and confirmation of Abivax’s addition to the Nasdaq Biotechnology Index. French media said Lilly representatives met with France’s Treasury about a possible acquisition, though Reuters could not confirm the meeting. Both companies declined to comment on the rumors.
22 December 2025
····
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

Abivax shares fell about 5% in U.S. and Paris trading after reporting a nine-month net loss of €254.1 million, up from €136.9 million a year earlier. Cash and cash equivalents stood at €589.7 million as of September 30, expected to fund operations into Q4 2027. Investors weighed widening losses against a strong cash position and ongoing takeover speculation.
16 December 2025
···

Stock Market Today

  • Bank of America Warns of 1994-Style Stock Market Shock Amid Persistent Inflation and Rising Yields
    June 13, 2026, 7:21 AM EDT. Bank of America cautions investors about a potential 1994-style market shock driven by sustained inflation, higher Treasury yields, and ongoing Federal Reserve tightening. With recent headline CPI near 4.2% and unemployment at 4.3%, the bank highlights the risk that inflation's slow cooling could push the annual rate above 5% by midterm elections. This scenario challenges the prevailing investor optimism for imminent Fed rate cuts, now not expected until 2027 per Goldman Sachs. Elevated Treasury yields increase the appeal of government bonds, complicating valuations for stocks, especially in mega-cap tech and AI sectors reliant on future profit growth. Bank of America draws parallels to 1994 when abrupt Fed rate hikes disrupted markets, underscoring the possibility of similar volatility today despite no immediate recession threat.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 13.06.2026

13 June 2026
LIVEMarkets rolling coverageStarted: June 13, 2026, 4:00 AM EDTUpdated: June 13, 2026, 7:22 AM EDT SpaceX IPO Faces Centuries-Old Market Challenge: Patient Investors Prevail June 13, 2026, 7:22 AM EDT. SpaceX’s potential IPO echoes the centuries-old challenge first seen with the Dutch East India Company (VOC) in 1602. Despite VOC’s real assets and government backing, its stock took decades to double. Modern IPO data supports similar caution: 60% of IPOs between 1975-2021 ended flat or lower after three years, according to University of Florida research. Market experts caution that most IPOs dip before gains and that well-known large IPOs like
SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
Go toTop